Alaxen 0.5 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Alprazolam |
| Company | United pharmaceuticals ltd |
| Also available as |
Title
Alaxen
Categories
- Anxiety Medication
- Sedatives
- Anxiolytics
- Benzodiazepines
Description
Alaxen is a medication indicated for anxiety disorder, short term relief of anxiety, anxiety associated with depression, panic disorder, with or without agoraphobia. It is a triazole analog of the 1,4-benzodiazepine class with anxiolytic, hypnotic, and anticonvulsive properties. The medication interacts with the Gamma Aminobutyric Acid (GABA)-benzodiazepine receptor complex. The usual starting dose is 0.25 mg, two or three times daily and may be gradually increased if needed and tolerated. The maximum dose should not exceed 4 mg/day. Alaxen has potential side effects such as drowsiness, light-headedness, depression, headache, confusion, dry mouth, and constipation. It is pregnancy category D and should be avoided during lactation. Alaxen should be administered with caution to patients with hepatic or renal disease, chronic pulmonary insufficiency, or sleep apnea. Safety and effectiveness of Alaxen in individuals below 18 years of age have not been established. Keep Alaxen below 30°C temperature, away from light & moisture, and out of the reach of children.
Attributes
- Indications:
- Anxiety disorder
- Short term relief of anxiety
- Anxiety associated with depression
- Panic disorder, with or without agoraphobia
- Pharmacology:
- Anxiolytic
- Hypnotic
- Anticonvulsive
- Interacts with GABA-benzodiazepine receptor complex
- Dosage & Administration:
- Usual starting dose of 0.25 mg
- Maximum dose should not exceed 4 mg/day
- Dosage should be individualized for maximum beneficial effect
- Gradual dosage reduction when discontinuing therapy
- Interaction:
- Aggravation by other psychotropic drugs
- Aggravation by anticonvulsants
- Aggravation by antihistaminics
- Aggravation by alcohol
- Aggravation by oral contraceptives
- Side Effects:
- Drowsiness
- Light-headedness
- Depression
- Headache
- Confusion
- Dry mouth
- Constipation
- Pregnancy & Lactation:
- Category D for pregnancy
- Excreted in breast milk
- Precautions & Warnings:
- Potential for psychological and physical dependence
- Caution in patients with hepatic or renal disease
- Caution in patients with chronic pulmonary insufficiency
- Caution in patients with sleep apnea
- Use in Special Populations:
- Safety and effectiveness not established in individuals below 18 years of age
- Overdose Effects:
- Somnolence
- Confusion
- Impaired coordination
- Diminished reflexes
- Coma
- Therapeutic Class:
- Benzodiazepine sedatives
- Storage Conditions:
- Keep below 30°C temperature
- Keep away from light & moisture
- Keep out of the reach of children